Agios Pharmaceuticals, Inc. · NASDAQ:AGIO

Bellevue Group AG reported a 6.10% stake in Agios Pharmaceuticals, Inc. (Schedule 13G)

Event Jun 1, 2025 · Filed Jul 7, 2025

Bellevue Group AG reported a 6.10% stake in Agios Pharmaceuticals, Inc., 3,515,150 shares, as a passive investor on Jun 1, 2025. Filed Jul 7, 2025 (Schedule 13G).

Stake
6.10%
Shares
3,515,150
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Bellevue Group AG6.10%3,515,150
Bellevue Asset Management AG6.10%3,515,150

Source

View original at SEC

Related